Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration.

The survival time for patients with PCNSL may be longer than previously thought, especially for patients with leptomeningeal seeding and lesions with hemorrhagic components Also, non-enhancing tumors may be less aggressive than enhancing tumors.